Sattva Neelapu, MD, Professor, Department of Lymphoma and Myeloma, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, discusses the role of off-the-shelf CAR natural killer (CAR NK) cell therapy in the treatment of B-cell malignancies.